Annual CFO
-$24.48 M
+$13.09 M+34.84%
31 December 2023
Summary:
Achieve Life Sciences annual cash flow from operations is currently -$24.48 million, with the most recent change of +$13.09 million (+34.84%) on 31 December 2023. During the last 3 years, it has fallen by -$11.01 million (-81.68%). ACHV annual CFO is now -170.18% below its all-time high of $34.88 million, reached on 31 December 2009.ACHV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$10.37 M
-$5.45 M-110.77%
30 September 2024
Summary:
Achieve Life Sciences quarterly cash flow from operations is currently -$10.37 million, with the most recent change of -$5.45 million (-110.77%) on 30 September 2024. Over the past year, it has dropped by -$5.24 million (-101.95%). ACHV quarterly CFO is now -123.51% below its all-time high of $44.11 million, reached on 31 December 2009.ACHV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$24.95 M
-$5.24 M-26.57%
30 September 2024
Summary:
Achieve Life Sciences TTM cash flow from operations is currently -$24.95 million, with the most recent change of -$5.24 million (-26.57%) on 30 September 2024. Over the past year, it has increased by +$6.31 million (+20.20%). ACHV TTM CFO is now -171.52% below its all-time high of $34.88 million, reached on 31 December 2009.ACHV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.8% | -102.0% | +20.2% |
| 3 y3 years | -81.7% | -19.3% | +6.6% |
| 5 y5 years | -130.4% | -237.6% | -62.6% |
ACHV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -81.7% | +34.8% | -137.7% | +8.3% | -26.6% | +36.2% |
| 5 y | 5 years | -130.4% | +34.8% | -371.9% | +8.3% | -89.8% | +36.2% |
| alltime | all time | -170.2% | +43.7% | -123.5% | +39.5% | -171.5% | +46.7% |
Achieve Life Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.37 M(+110.8%) | -$24.95 M(+26.6%) |
| June 2024 | - | -$4.92 M(-6.9%) | -$19.71 M(-8.2%) |
| Mar 2024 | - | -$5.29 M(+21.2%) | -$21.46 M(-12.3%) |
| Dec 2023 | -$24.48 M(-34.8%) | -$4.36 M(-15.0%) | -$24.48 M(-21.7%) |
| Sept 2023 | - | -$5.14 M(-23.1%) | -$31.26 M(-16.5%) |
| June 2023 | - | -$6.68 M(-19.6%) | -$37.43 M(-4.3%) |
| Mar 2023 | - | -$8.30 M(-25.5%) | -$39.09 M(+4.1%) |
| Dec 2022 | -$37.57 M(+27.6%) | -$11.14 M(-1.5%) | -$37.57 M(+18.7%) |
| Sept 2022 | - | -$11.31 M(+35.6%) | -$31.64 M(+9.0%) |
| June 2022 | - | -$8.34 M(+23.0%) | -$29.03 M(-2.5%) |
| Mar 2022 | - | -$6.78 M(+29.9%) | -$29.77 M(+1.1%) |
| Dec 2021 | -$29.44 M(+118.5%) | -$5.22 M(-40.0%) | -$29.44 M(+10.3%) |
| Sept 2021 | - | -$8.69 M(-4.2%) | -$26.70 M(+19.5%) |
| June 2021 | - | -$9.08 M(+40.7%) | -$22.34 M(+44.5%) |
| Mar 2021 | - | -$6.45 M(+160.2%) | -$15.46 M(+14.8%) |
| Dec 2020 | -$13.47 M(-11.4%) | -$2.48 M(-42.8%) | -$13.47 M(-6.5%) |
| Sept 2020 | - | -$4.33 M(+97.2%) | -$14.41 M(+9.6%) |
| June 2020 | - | -$2.20 M(-50.7%) | -$13.14 M(-11.1%) |
| Mar 2020 | - | -$4.46 M(+30.7%) | -$14.79 M(-2.8%) |
| Dec 2019 | -$15.22 M(+43.2%) | -$3.41 M(+11.1%) | -$15.22 M(-0.8%) |
| Sept 2019 | - | -$3.07 M(-20.0%) | -$15.34 M(+0.6%) |
| June 2019 | - | -$3.84 M(-21.4%) | -$15.25 M(+14.9%) |
| Mar 2019 | - | -$4.89 M(+38.1%) | -$13.28 M(+25.0%) |
| Dec 2018 | -$10.62 M(+16.6%) | -$3.54 M(+18.8%) | -$10.62 M(-0.8%) |
| Sept 2018 | - | -$2.98 M(+59.6%) | -$10.71 M(-18.8%) |
| June 2018 | - | -$1.87 M(-16.3%) | -$13.18 M(+16.3%) |
| Mar 2018 | - | -$2.23 M(-38.4%) | -$11.33 M(+24.4%) |
| Dec 2017 | -$9.11 M(+4408.4%) | -$3.62 M(-33.6%) | -$9.11 M(-153.5%) |
| Sept 2017 | - | -$5.46 M(>+9900.0%) | $17.02 M(+11.9%) |
| June 2017 | - | -$18.00 K(+63.6%) | $15.21 M(+71.4%) |
| Mar 2017 | - | -$11.00 K(-100.0%) | $8.87 M(-4493.1%) |
| Dec 2016 | -$202.00 K(-97.8%) | $22.50 M(-409.8%) | -$202.00 K(-99.4%) |
| Sept 2016 | - | -$7.26 M(+14.3%) | -$33.39 M(-3.9%) |
| June 2016 | - | -$6.35 M(-30.1%) | -$34.76 M(+196.0%) |
| Mar 2016 | - | -$9.09 M(-15.0%) | -$11.74 M(+29.0%) |
| Dec 2015 | -$9.10 M(-47.4%) | -$10.69 M(+23.8%) | -$9.10 M(+69.8%) |
| Sept 2015 | - | -$8.63 M(-151.8%) | -$5.36 M(+115.4%) |
| June 2015 | - | $16.66 M(-358.5%) | -$2.49 M(-88.7%) |
| Mar 2015 | - | -$6.44 M(-7.2%) | -$22.06 M(+27.5%) |
| Dec 2014 | -$17.31 M(-51.8%) | -$6.94 M(+20.6%) | -$17.31 M(-3.3%) |
| Sept 2014 | - | -$5.76 M(+97.8%) | -$17.90 M(-20.0%) |
| June 2014 | - | -$2.91 M(+72.1%) | -$22.37 M(-16.9%) |
| Mar 2014 | - | -$1.69 M(-77.6%) | -$26.93 M(-25.0%) |
| Dec 2013 | -$35.93 M(-17.4%) | -$7.54 M(-26.3%) | -$35.93 M(-5.2%) |
| Sept 2013 | - | -$10.23 M(+37.0%) | -$37.89 M(-6.7%) |
| June 2013 | - | -$7.47 M(-30.2%) | -$40.59 M(-13.3%) |
| Mar 2013 | - | -$10.69 M(+12.6%) | -$46.80 M(+7.6%) |
| Dec 2012 | -$43.49 M(+114.6%) | -$9.50 M(-26.6%) | -$43.49 M(+13.2%) |
| Sept 2012 | - | -$12.94 M(-5.4%) | -$38.44 M(+21.3%) |
| June 2012 | - | -$13.68 M(+85.3%) | -$31.69 M(+34.3%) |
| Mar 2012 | - | -$7.38 M(+66.3%) | -$23.60 M(+16.5%) |
| Dec 2011 | -$20.26 M(-24.5%) | -$4.44 M(-28.3%) | -$20.26 M(+3.7%) |
| Sept 2011 | - | -$6.19 M(+10.8%) | -$19.53 M(+4.4%) |
| June 2011 | - | -$5.59 M(+38.2%) | -$18.71 M(+36.3%) |
| Mar 2011 | - | -$4.04 M(+9.0%) | -$13.73 M(-48.8%) |
| Dec 2010 | -$26.84 M | -$3.71 M(-31.0%) | -$26.84 M(-227.9%) |
| Sept 2010 | - | -$5.37 M(+783.9%) | $20.98 M(-11.4%) |
| June 2010 | - | -$608.00 K(-96.5%) | $23.68 M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$17.15 M(-138.9%) | $20.77 M(-40.5%) |
| Dec 2009 | $34.88 M(-383.4%) | $44.11 M(-1744.2%) | $34.88 M(-346.7%) |
| Sept 2009 | - | -$2.68 M(-23.7%) | -$14.14 M(+75.9%) |
| June 2009 | - | -$3.52 M(+15.8%) | -$8.04 M(-19.6%) |
| Mar 2009 | - | -$3.04 M(-38.0%) | -$9.99 M(-18.8%) |
| Dec 2008 | -$12.31 M(-47.3%) | -$4.90 M(-243.4%) | -$12.31 M(-6.6%) |
| Sept 2008 | - | $3.42 M(-162.5%) | -$13.18 M(-34.5%) |
| June 2008 | - | -$5.47 M(+2.2%) | -$20.11 M(+4.5%) |
| Mar 2008 | - | -$5.35 M(-7.3%) | -$19.24 M(-17.5%) |
| Dec 2007 | -$23.34 M(+18.6%) | -$5.77 M(+64.5%) | -$23.34 M(+13.9%) |
| Sept 2007 | - | -$3.51 M(-23.8%) | -$20.48 M(-10.7%) |
| June 2007 | - | -$4.60 M(-51.2%) | -$22.93 M(-17.5%) |
| Mar 2007 | - | -$9.44 M(+223.6%) | -$27.78 M(+41.2%) |
| Dec 2006 | -$19.68 M(+135.4%) | -$2.92 M(-51.0%) | -$19.68 M(+90.8%) |
| Sept 2006 | - | -$5.96 M(-37.0%) | -$10.31 M(+3.6%) |
| June 2006 | - | -$9.46 M(+605.0%) | -$9.96 M(+130.3%) |
| Mar 2006 | - | -$1.34 M(-120.8%) | -$4.33 M(-48.3%) |
| Dec 2005 | -$8.36 M(-42.8%) | $6.45 M(-215.1%) | -$8.36 M(-56.2%) |
| Sept 2005 | - | -$5.60 M(+46.4%) | -$19.08 M(+11.4%) |
| June 2005 | - | -$3.83 M(-28.8%) | -$17.13 M(+4.7%) |
| Mar 2005 | - | -$5.38 M(+25.7%) | -$16.37 M(+12.0%) |
| Dec 2004 | -$14.62 M(+47.5%) | -$4.28 M(+17.2%) | -$14.62 M(+8.9%) |
| Sept 2004 | - | -$3.65 M(+19.2%) | -$13.42 M(+12.5%) |
| June 2004 | - | -$3.06 M(-15.5%) | -$11.93 M(+5.2%) |
| Mar 2004 | - | -$3.63 M(+17.7%) | -$11.34 M(+14.5%) |
| Dec 2003 | -$9.91 M(-4.7%) | -$3.08 M(+42.6%) | -$9.91 M(+2.1%) |
| Sept 2003 | - | -$2.16 M(-12.7%) | -$9.70 M(-5.3%) |
| June 2003 | - | -$2.47 M(+12.9%) | -$10.25 M(-2.1%) |
| Mar 2003 | - | -$2.19 M(-23.8%) | -$10.47 M(+0.7%) |
| Dec 2002 | -$10.40 M(-932.5%) | -$2.87 M(+6.3%) | -$10.40 M(+10.4%) |
| Sept 2002 | - | -$2.71 M(+0.3%) | -$9.42 M(+251.2%) |
| June 2002 | - | -$2.70 M(+27.1%) | -$2.68 M(+781.1%) |
| Mar 2002 | - | -$2.12 M(+12.2%) | -$304.30 K(-124.4%) |
| Dec 2001 | $1.25 M(-131.4%) | -$1.89 M(-146.9%) | $1.25 M(-1.4%) |
| Sept 2001 | - | $4.03 M(-1359.0%) | $1.27 M(-126.3%) |
| June 2001 | - | -$320.10 K(-43.7%) | -$4.82 M(+98.7%) |
| Mar 2001 | - | -$568.60 K(-69.7%) | -$2.43 M(-38.9%) |
| Dec 2000 | -$3.97 M(+3874.1%) | -$1.87 M(-9.0%) | -$3.97 M(+975.5%) |
| Sept 2000 | - | -$2.06 M(-199.2%) | -$369.50 K(-110.4%) |
| June 2000 | - | $2.08 M(-198.2%) | $3.56 M(-489.4%) |
| Mar 2000 | - | -$2.11 M(-222.3%) | -$914.80 K(+814.8%) |
| Dec 1999 | -$100.00 K(-99.0%) | $1.73 M(-7.5%) | -$100.00 K(-98.0%) |
| Sept 1999 | - | $1.87 M(-177.9%) | -$5.03 M(-38.7%) |
| June 1999 | - | -$2.40 M(+84.6%) | -$8.20 M(-1.2%) |
| Mar 1999 | - | -$1.30 M(-59.4%) | -$8.30 M(-19.4%) |
| Dec 1998 | -$10.30 M(-835.7%) | -$3.20 M(+146.2%) | -$10.30 M(+47.1%) |
| Sept 1998 | - | -$1.30 M(-48.0%) | -$7.00 M(+9.4%) |
| June 1998 | - | -$2.50 M(-24.2%) | -$6.40 M(+156.0%) |
| Mar 1998 | - | -$3.30 M(-3400.0%) | -$2.50 M(-278.6%) |
| Dec 1997 | $1.40 M(-60.0%) | $100.00 K(-114.3%) | $1.40 M(-70.2%) |
| Sept 1997 | - | -$700.00 K(-150.0%) | $4.70 M(-44.0%) |
| June 1997 | - | $1.40 M(+133.3%) | $8.40 M(+6.3%) |
| Mar 1997 | - | $600.00 K(-82.4%) | $7.90 M(+125.7%) |
| Dec 1996 | $3.50 M(-144.9%) | $3.40 M(+13.3%) | $3.50 M(+3400.0%) |
| Sept 1996 | - | $3.00 M(+233.3%) | $100.00 K(-103.4%) |
| June 1996 | - | $900.00 K(-123.7%) | -$2.90 M(-23.7%) |
| Mar 1996 | - | -$3.80 M | -$3.80 M |
| Dec 1995 | -$7.80 M(+122.9%) | - | - |
| Dec 1994 | -$3.50 M | - | - |
FAQ
- What is Achieve Life Sciences annual cash flow from operations?
- What is the all time high annual CFO for Achieve Life Sciences?
- What is Achieve Life Sciences annual CFO year-on-year change?
- What is Achieve Life Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly CFO year-on-year change?
- What is Achieve Life Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Achieve Life Sciences?
- What is Achieve Life Sciences TTM CFO year-on-year change?
What is Achieve Life Sciences annual cash flow from operations?
The current annual CFO of ACHV is -$24.48 M
What is the all time high annual CFO for Achieve Life Sciences?
Achieve Life Sciences all-time high annual cash flow from operations is $34.88 M
What is Achieve Life Sciences annual CFO year-on-year change?
Over the past year, ACHV annual cash flow from operations has changed by +$13.09 M (+34.84%)
What is Achieve Life Sciences quarterly cash flow from operations?
The current quarterly CFO of ACHV is -$10.37 M
What is the all time high quarterly CFO for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly cash flow from operations is $44.11 M
What is Achieve Life Sciences quarterly CFO year-on-year change?
Over the past year, ACHV quarterly cash flow from operations has changed by -$5.24 M (-101.95%)
What is Achieve Life Sciences TTM cash flow from operations?
The current TTM CFO of ACHV is -$24.95 M
What is the all time high TTM CFO for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM cash flow from operations is $34.88 M
What is Achieve Life Sciences TTM CFO year-on-year change?
Over the past year, ACHV TTM cash flow from operations has changed by +$6.31 M (+20.20%)